Mark Cuban’s Cost Plus Drug Company has partnered with healthcare technology and diagnostics company Binx Health, to increase access to affordable healthcare and medications across the U.S.
Binx Health provides a digital platform on which patients can get tested and diagnosed for a variety of common health issues such as diabetes, heart disease, and sexually transmitted infections (STIs). The partnership will enable users to receive testing and results through the platform, Binx Everywhere, and receive affordable medication through the Cost Plus Drugs online prescription program. Cost Plus Drugs online pharmacy launched in January 2022, and has over 1,000 prescription products available via mail delivery.
Through the collaboration, the companies are aiming to reduce health inequalities and disparities, providing testing for those who are uninsured or underinsured, and providing customers with lower prescription drug prices.
"Our mission has always been and continues to be increasing access to necessary care for all. By promoting the Mark Cuban Cost Plus Drug Company, we are taking that mission to the next level, providing patients with convenient diagnostic testing necessary to receive their medications," Abby Wright, vice president of business development and market access at Binx Health, said in the release. "We believe that every patient deserves the highest level of care, regardless of their background, circumstance, geographical location, and coverage status."
Click here to read the original news story